Skip to content

Source Monitoring Déficit in Neuropsychiatric Population

Source Monitoring Déficit in Neuropsychiatric Population

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03886584
Enrollment
300
Registered
2019-03-22
Start date
2019-03-08
Completion date
2026-07-31
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric Disorder

Keywords

Bipolar Disorder, Source-monitoring

Brief summary

the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-monitoring will be measured thanks to internal- and reality-monitoring informatic tasks.The investigators hypothesized patients with fronto-temporal abnormalities would show more marked deficits than patients with only frontal abnormalities.

Detailed description

Source-monitoring abilities will be measured thanks to reality-monitoring testing (i.e. the ability to distinguish internal-generated events from external ones) and internal-monitoring testing (i.e. the ability to distinguish an imagined source from a performed one). A source-monitoring deficit have been demonstrated in patients with psychiatric conditions such as schizophrenia and seems linked to frontotemporal abnormalities (frontotemporal dysconnectivity and temporal hypoactivity). With a total of 150 patients, the investigators will include 30 patients per group: patients with pre-dementia stage Alzheimer, Alzheimer, Fronto-Temporal dementia, Lewy Body dementia or Parkinson and Bipolar Disorder, with the hypothesis that Bipolar Disorder patients will present less marked deficit. The investigators will recruit 150 healthy controls.

Interventions

OTHERMonitoring source test

Internal- and external-monitoring correct responses and inversions

Sponsors

Hôpital le Vinatier
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

2 arms

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects who gave their free and informed consent; * Men and women; * Aged 18 to 80; * Having normal or corrected vision; * Mastering the French language (read and spoken); * All subjects will not have a working memory deficit preventing the test from being passed (MMSE short version):AM patients should have a score of \<MMSE \<26; Patients with pre-dementia AD will be diagnosed according to Dubois criteria (Dubois et al., 2016); patients with early FTD will be diagnosed according to Rascovsky's criteria (Rascovsky et al., 2011); Patients with DCL will be diagnosed according to McKeith's criteria (McKeith et al., 2005), TBP patients will be diagnosed using DSM 5 criteria (Arlington VA, 2013).

Exclusion criteria

* Inadmissibility of the consent or refusal of the subject. * Patients under guardianship

Design outcomes

Primary

MeasureTime frameDescription
measure source memory performanceone yearin patients with neuropsychiatric disorders with or without temporal involvement (pre-dementia Alzheimer's disease, Alzheimer's disease - AD, fronto-temporal dementia - DFT, Lewy body dementia - DCL and bipolar disorder - TBP) and healthy volunteers matched in age, gender, and level of education.

Secondary

MeasureTime frameDescription
measure the recognition of distractorsone yearwords not presented during the source monitoring test phase but presented during the recall phase. This measure will allow us to avoid that a disturbance invading the working memory or attentional capacities does not compromise the good realization of the task.

Countries

France

Contacts

Primary ContactJEROME BRUNELIN, PHD
jerome.brunelin@ch-le-vinatier.fr00334 37 91 55 65
Backup ContactJean-Michel DOREY, PHD
jean-michel.dorey@ch-le-vinatier.fr00334 37 91 52 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026